Federated Hermes, Inc. Lucira Health, Inc. Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.94 - $8.94 $135,785 - $245,733	-27,487 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.81 $287,453 - $513,615	-47,513 Reduced 63.35%	27,487 $209,000
Q2 2021 Aug 16, 2021	SELL	$4.56 - $11.45 $2.28 Million - $5.72 Million	-499,756 Reduced 86.95%	75,000 $498,000
Q1 2021 May 13, 2021	BUY	$11.65 - $37.0 $6.7 Million - $21.3 Million	574,756 New	574,756 $6.96 Million

Ticker LHDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,106,500
Market Cap $1.2M
Description
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a paten...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.